In the debate over the economic stimulus bill, it seemed like all politicians wanted to talk about was “shovel-ready” infrastructure projects. Congress’s love for roads and bridges notwithstanding, lawmakers did include a significant chunk of money for “shovel-ready” scientific research. The National Institute of Allergy and Infectious Diseases will get $1.12 billion from […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]